Who Exports Pazopanib from India — 109 Suppliers Behind a $8.3M Market

Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes over 40% of the country's bulk drug production. The city hosts more than 2,000 pharmaceutical companies, including major players like Dr. Reddy's Laboratories and Aurobindo Pharma. The establishment of Hyderabad Pharma City, recognized as a National Investment Manufacturing Zone in December 2019, further solidifies its position as a pharmaceutical hub. This ecosystem provides a robust infrastructure for the production of active pharmaceutical ingredients (APIs) essential for drugs like Pazopanib.

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations industry. Vadodara, in particular, is home to Alembic Pharmaceuticals, a company with a significant presence in the production of formulations. The region's pharmaceutical industry benefits from a skilled workforce and a supportive regulatory environment, making it a key player in the formulation and export of medications such as Pazopanib.

The Mumbai-Thane-Raigad belt serves as a critical export gateway for India's pharmaceutical products. Mumbai, being a major port city, facilitates the efficient export of pharmaceuticals to global markets. The region's well-established logistics and regulatory framework support the seamless export of drugs like Pazopanib, ensuring timely delivery to destinations such as the United States, which accounts for the majority of Pazopanib exports.

Baddi-Nalagarh in Himachal Pradesh is known for its tax incentives, attracting numerous pharmaceutical companies to set up manufacturing units. This zone offers benefits such as excise duty exemptions and income tax holidays, reducing production costs. While primarily focused on domestic supply, the cost advantages can be leveraged for competitive pricing in international markets for drugs like Pazopanib.

• Leverage Hyderabad's API Production: Given Hyderabad's dominance in bulk drug manufacturing, sourcing Pazopanib APIs from this region can ensure quality and cost-effectiveness.

• Utilize Gujarat's Formulation Expertise: Engaging with manufacturers in the Ahmedabad-Vadodara corridor can provide access to high-quality formulations, benefiting from the region's established infrastructure and skilled workforce.

• Optimize Export Logistics via Mumbai: Utilizing the Mumbai-Thane-Raigad region's export facilities can facilitate efficient and timely delivery of Pazopanib to key markets, particularly the United States.

• Consider Cost Advantages in Baddi-Nalagarh: Exploring manufacturing partnerships in the Baddi-Nalagarh tax incentive zone can offer cost benefits, potentially enhancing competitive pricing for Pazopanib in international markets.

By strategically engaging with these pharmaceutical clusters, TransData Nexus can optimize the supply chain for Pazopanib, ensuring quality production and efficient distribution to meet global demand.